TACT Principal Investigator Reflects On A Long And Contentious Journey

gervasio-lamas

In a fascinating and important blog post, Gervasio Lamas offers a deeply personal perspective on the long and contentious journey of the Trial to Assess Chelation Therapy (TACT), for which he was the principal investigator. Here are a few quotes from his post, but I can’t urge you strongly enough to read the entire post over…

Click here to continue reading…

TACT Substudy Suggests Possible Strong Benefit for Chelation in Diabetics

One year ago the results of the TACT trial were published in JAMA, sparking an enormous controversy over the propriety of publishing a trial suggesting that chelation therapy might be beneficial in people with cardiovascular disease. Chelation therapy has long been a staple of alternative medicine, but until the publication of TACT it had received no credit whatsoever in…

Click here to continue reading…

NIH Trial Gives Surprising Boost To Chelation Therapy

With a result that is likely to surprise and baffle much of the mainstream medical community, a large NIH-sponsored trial has turned up the first substantial evidence in support of chelation therapy for patients with coronary disease.  Known as TACT (Trial to Assess Chelation Therapy),  the highly controversial trial was presented today at the AHA by Gervasio…

Click here to continue reading…